Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson’s Disease, recent trial suggests Post author: Post published:December 5, 2023 Post category:uncategorized A safe and feasible treatment option for reducing the motor signs of Parkinson’s disease. You Might Also Like Community exercise helps older adults maintain fitness and strength August 19, 2025 Fat-producing enzyme identified as key driver of damage in Parkinson’s disease April 9, 2026 New report highlights a rare case of 5-fluorouracil-induced hyperammonemic encephalopathy February 5, 2026
New report highlights a rare case of 5-fluorouracil-induced hyperammonemic encephalopathy February 5, 2026